(Press-News.org) Andrew Wakefield, the disgraced doctor who claimed a link between MMR and autism, planned secret businesses intended to make huge sums of money, in Britain and America, from his now-discredited allegations.
The Wakefield scheme is exposed today in the second part of a BMJ series of special reports, "Secrets of the MMR scare", by investigative journalist Brian Deer. Last week we revealed the scientific fraud behind the appearance of a link between the vaccine and autism. Now Deer follows the money.
Drawing on investigations and documents obtained under the Freedom of Information Act, the report shows how Wakefield's institution, the Royal Free Medical School in London, supported him as he sought to exploit the MMR scare for financial gain.
It reveals how Wakefield met with medical school managers to discuss a joint business even while the first child to be fully investigated in his research was still in the hospital, and how just days after publication of that research, which triggered the health crisis in 1998, he brought business associates to the Royal Free to continue negotiations.
One business, named after Wakefield's wife, intended to develop Wakefield's own "replacement" vaccines, diagnostic testing kits and other products which only stood any real chance of success if public confidence in MMR was damaged.
Documents reveal the planned shareholdings of Wakefield and his collaborators, and how much Wakefield expected to receive personally. Financial forecasts made available for the first time today show Wakefield and his associates predicting they could make up to £28 million ($43,367,082; €33,290,350) a year from the diagnostic kits alone.
"It is estimated that the initial market for the diagnostic will be litigation driven testing of patients with AE [autistic enterocolitis] from both the UK and the USA," said a 35 page "private and confidential" prospectus obtained by Deer, aimed at raising an initial £700,000 from investors. "It is estimated that by year 3, income from this testing could be about £3,300,000 rising to about £28,000,000 as diagnostic testing in support of therapeutic regimes come on stream."
Deer's investigation also reveals today that Wakefield was offered support to try to replicate his results, gained from just 12 children, with a larger validated study of up to 150 patients, but that he refused to carry out the work, claiming that his academic freedom would be jeopardised. His research claims have never been replicated.
INFORMATION: END
The drugs include traditional non-steroidal anti-inflammatory drugs (NSAIDS) as well as new generation anti-inflammatory drugs, known as COX-2 inhibitors.
The researchers say that doctors and patients need to be aware that prescription of any anti-inflammatory drug needs to take cardiovascular risk into account.
NSAIDs have been the cornerstone of managing pain in patients with osteoarthritis and other painful conditions. In 2004, the COX-2 inhibitor rofecoxib was withdrawn from the market after a trial found that the drug increased the risk of cardiovascular disease. ...
The blood test could mean that 98% of invasive procedures could be avoided, say the authors. The test uses the latest DNA technology to analyse genetic components in the mother's blood that indicate whether the foetus has Down's.
Down's syndrome or trisomy 21 occurs in around 1 in 800 births and older women are at higher risk.
Women in high risk groups tend to undergo a combination of scans and hormone level tests in order to determine if they need to have an invasive test such as amniocentesis or chorionic villus sampling. The latter tests take samples of genetic ...
Cambridge, MASS. -- Researchers at MIT and Brigham and Women's Hospital have shown that they can deliver the cancer drug cisplatin much more effectively and safely in a form that has been encapsulated in a nanoparticle targeted to prostate tumor cells and is activated once it reaches its target.
Using the new particles, the researchers were able to successfully shrink tumors in mice, using only one-third the amount of conventional cisplatin needed to achieve the same effect. That could help reduce cisplatin's potentially severe side effects, which include kidney damage ...
Tom Jefferson and colleagues from the Cochrane Group argue that the current system for assessing the safety and effectiveness of drugs, based on published trial data only, is "wholly inadequate" and "ethically dubious."
They propose a new approach that would allow in-depth scrutiny of the complete set of trial data for a new drug.
Their call comes after they reviewed the evidence for the antiviral drug oseltamivir (Tamiflu), and were unable to find sufficient published data to support the conclusion that oseltamivir reduces complications in healthy adults.
As a result, ...
CHICAGO—Hearing loss can affect anyone, at any time. But it can be especially frightening for someone who suddenly starts to lose his hearing during adulthood. Tom Groves, 77, first noticed his diminishing hearing when he was in his early 40s. He was unable to hold conversations with large groups of people; found it nearly impossible to socialize in high-background noise environments like restaurants; and couldn't enjoy radio, TV and movies unless they were captioned. Now, Groves is hearing much better than he has in 30 years, thanks to an experimental hybrid cochlear implant. ...
Gender stereotypes suggest that men are usually tough and women are usually tender. A new study published in Psychological Science, a journal of the Association for Psychological Science, finds these stereotypes have some real bodily truth for our brains; when people look at a gender-neutral face, they are more likely to judge it as male if they're touching something hard and as female if they're touching something soft.
Several studies have found recently that we understand many concepts through our bodies. For example, weight conveys importance; just giving someone ...
"Vive la difference!" Seeing foreigners as foreign encourages local coworkers to assist them finds a Rotman study.
Toronto - Whether it's a company with local and ex-pat employees, countries in need of aid, or the elderly interacting with the young, a new research paper to be published in the journal Psychological Science says recognizing diversity can actually encourage people to help each other instead of sparking conflict.
"The standard assumption has been that group-based differences serve as the basis for distrust, disagreement, or dispute," says Geoffrey Leonardelli, ...
(Boston) – Researchers from Boston University School of Medicine (BUSM), in collaboration with colleagues at Lahey Clinic and from Denmark and Germany, have found that 5a-reductase inhibitors (5a-RIs), while improving urinary symptoms in patients with benign prostatic hyperplasia (BPH) and possible hair loss prevention, produces significant adverse effects in some individuals including loss of libido, erectile dysfunction (ED), ejaculatory dysfunction and potential depression. These findings, which currently appear on-line in Journal of Sexual Medicine, suggest that extreme ...
New research suggests eating vegetables gives you a healthy tan. The study, led by Dr Ian Stephen at The University of Nottingham, showed that eating a healthy diet rich in fruit and vegetables gives you a more healthy golden glow than the sun.
The research, which showed that instead of heading for the sun the best way to look good is to munch on carrots and tomatoes, has been published in the journal Evolution and Human Behaviour.
Dr Ian Stephen, from the School of Psychology, University of Nottingham, Malaysia Campus, led the research as part of his PhD at the University ...
Montreal, January 10, 2011 – A research team from the McGill University Health Centre (MUHC) and McGill University has demonstrated that private rooms in the Intensive Care Unit (ICU) play a key role in reducing hospital infections like C-difficile. The study, published today in the journal Archives of Internal Medicine, also suggests that length of stay would be shorter and this could lead to cost savings to the healthcare system.
Infection control in hospitals is a worldwide health concern that can have a serious impact on patient morbidity, mortality and the cost of ...
